A multidisciplinary clinical team led by Professor Bernat Soria from the Institute of Bioengineering at the Miguel Hernández ...

Researchers are studying why the energy factories are moving between cells and whether the process can be harnessed to treat ...

Recent research sheds light on how changes in the chemical structure of a protein called Interleukin-6 affect lung cancer’s ...

Although lung cancer screening is recommended in the ... oxygen from the lungs to every other organ, and blood-forming stem cells must make about 200 billion new red blood cells each day to ...

Hypoxic induction of NOTCH signaling enhances survival of NSCLC through effects on lung cancer stem cells Upregulation of Notch signaling under hypoxic conditions is important for cellular ...

Lung cancer (LC) is a major global health issue, with high mortality rates and limited therapeutic options. It is primarily categorized into non-small cell lung cancer (NSCLC) and small cell lung ...

Tarlatamab is a bispecific T-cell engager that binds to DLL3 expressed on the surface of tumor cells and CD3 expressed on the surface of T-cells.

Researchers have developed drug-delivering aptamers that can deliver a cytotoxic double punch to leukemic stem cells.

Although lung cancer screening is recommended in the ... oxygen from the lungs to every other organ, and blood-forming stem cells must make about 200 billion new red blood cells each day to ...

Imdelltra is associated with improvement in overall survival compared to local standard-of-care chemotherapy among patients with small cell lung cancer.